Literature DB >> 14731999

Delay in the diagnosis of breast cancer: medico-legal implications.

B T Andrews1, T Bates.   

Abstract

Delay in the diagnosis of breast cancer is an important cause of medical malpractice claims which if trends continue, will threaten healthcare budgets. Most malpractice claims are made by younger women. Delay is most frequently due to the physician failing to be impressed with the clinical findings, or to a false negative mammogram report. Diagnosis of breast cancer is more difficult in younger women, because of the poor sensitivity of diagnostic tests and the high prevalence of benign disease in this age group. Models of tumour growth suggest that the potential to metastasize may be present before the tumour is clinically detectable and that if the growth rate of a given tumour is constant, any clinical delay is a small proportion of the lifespan of the tumour. Patient delay is generally associated with more advanced lesions at presentation, but the effect of delay on survival or what period of delay is significant remains uncertain. Delay in the diagnosis of breast cancer is likely to cause the patient considerable anxiety, especially when the public understands that the aim of mammographic screening is to diagnose breast cancer at an early stage in order to effect a cure. For a plaintiff to successfully claim in court she must prove that she has suffered an injury, and that the injury was the result of negligent medical practice. It is easier to defend a case of delay in diagnosis if the documentation is in order and all the appropriate tests have been performed.

Entities:  

Year:  2000        PMID: 14731999     DOI: 10.1054/brst.1999.0121

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  6 in total

1.  Huge undifferentiated fibroblastic sarcoma of the foot and lower leg: impact of diagnostic delay and discussion of an entity.

Authors:  Cornelia S L Müller; Claudia Pföhler; Dieter Kohn; Thomas Vogt
Journal:  BMJ Case Rep       Date:  2013-10-11

2.  Length of symptoms before referral: prognostic variable for high-grade soft tissue sarcoma?

Authors:  Bruce T Rougraff; Jackie Lawrence; Kenneth Davis
Journal:  Clin Orthop Relat Res       Date:  2012-03       Impact factor: 4.176

3.  Marrying Story with Science: The Impact of Outdated and Inconsistent Breast Cancer Screening Practices in Canada.

Authors:  Jennie Dale; Michelle Di Tomaso; Victoria Gay
Journal:  Curr Oncol       Date:  2022-05-13       Impact factor: 3.109

Review 4.  Screening for cancer: valuable or not?

Authors:  Frank L Meyskens
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

5.  Factors that influence treatment delay in patients with colorectal cancer.

Authors:  Irene Zarcos-Pedrinaci; Alberto Fernández-López; Teresa Téllez; Francisco Rivas-Ruiz; Antonio Rueda; María Manuela Morales Suarez-Varela; Eduardo Briones; Marisa Baré; Antonio Escobar; Cristina Sarasqueta; Nerea Fernández de Larrea; Urko Aguirre; José María Quintana; Maximino Redondo
Journal:  Oncotarget       Date:  2017-05-30

6.  Machine learning-based prediction of breast cancer growth rate in vivo.

Authors:  Shristi Bhattarai; Sergey Klimov; Mohammed A Aleskandarany; Helen Burrell; Anthony Wormall; Andrew R Green; Padmashree Rida; Ian O Ellis; Remus M Osan; Emad A Rakha; Ritu Aneja
Journal:  Br J Cancer       Date:  2019-08-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.